Boston Launches New Ferry to Flynn Marine Park
Commuters on the MBTA’s regional rail system just got an option to add a little more fluidity to their commute. And Seaport landlords just got a new amenity to promote to potential tenants.
Vertex Pharmaceuticals’ Fan Pier HQ Refinanced for $1B
Newton-based RMR Group refinanced its Boston Fan Pier property for $1 billion, a year after Vertex Pharmaceuticals renewed its lease for the 1.1 million square-foot office and lab complex.
Lender Buys Fort Point Lab Conversion for $57M
Starwood Property Trust acquired a Fort Point office building that was converted into lab space by the previous owners for $57.2 million.
Vertex HQ Renewal Deals Blow to Lab Projects
Vertex Pharmaceuticals’ headquarters move to the Fan Pier in 2014 put Boston’s Seaport District on the map as a life science industry destination. Vertex’ reported decision to remain at the Fan Pier beyond 2028 deals a blow to a growing list of major lab projects still seeking tenants in the neighborhood.
Related Beal Closes on Financing for Vertex Lab Project
A development group led by Related Beal completed its financing for development of a Vertex Pharmaceutical-leased research center that’s ramping up construction in South Boston’s Raymond L. Flynn Marine Park.
Developers Line Up to Lure Vertex HQ
As Vertex Pharmaceuticals weighs whether to relocate its headquarters, Boston-based Beacon Capital Partners is aggressively pursuing a new lab project that could lure the life science firm from its Fan Pier perch.
Burlington Plants a Biotech Flag
Corporate headquarters ribbon-cuttings attract headlines and VIPs, but developers in Burlington say early-stage biotechs will be key to expanding Boston suburbs’ newest life science cluster.
Lab Rents Dip in Seaport, Cambridge
Asking rents for lab space in two of the highest-priced local submarkets – Cambridge and Boston’s Seaport District – dipped in the second quarter amid an uptick in subleasing activity.
Cambridge Retains Lab Market Lead
Life science landlords continue to enjoy the upper hand in Greater Boston as the vacancy rate for the nearly 35 million-square-foot lab market remains below 3 percent, according to Colliers International research.
Vertex to Anchor Next Marine Park Lab Development
Vertex Pharmaceuticals will occupy a new life science building at 22 Drydock Ave. in South Boston, bringing its commercial footprint in the neighborhood to over 1.9 million square feet.
This Month in History: Boston’s ‘Innovation District’ Is Born
Former Mayor Thomas Menino’s ambitious vision to transform the 1,000-acre South Boston waterfront into an “innovation district” came alive Jan. 25, 2011, when Vertex Pharmaceuticals announced plans to relocate to a giant, new headquarters there.
BPDA Set to Offer Life Science Parcel in Marine Park
A nearly 2-acre site in the South Boston marine park is set to be offered for redevelopment as potential life science space in one of the industry’s most active frontiers.
Hot Property: Vertex Seaport Offices
Boston-based architecture firm Tria has been selected to design Vertex Pharmaceuticals’ new cell and genetic therapies center in Boston’s Seaport District.
Promoting ‘Coopetition’ from Cambridge, MA to Cambridge, UK
Bill Kane got in on the ground floor of Kendall Square’s life science boom. Now the East Coast and U.K. leader for BioMed Realty, Kane oversees a Greater Boston portfolio that’s over 98 percent leased. But BioMed is still finding ways to grow in industry nucleus Kendall Square.
Vertex-Backed Startup Commits to Arsenal Yards
A three-year-old Kendall Square biotech startup that received a $70 million investment from Vertex Pharmaceuticals in May is joining Watertown’s expanding life science corridor.
BRA To Fallon: Turn Down The Lights
The Vertex Pharmaceuticals headquarters and Twenty...
